Gihan Hamdy Elsisi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

Positive Breast Cancer

Systemic Lupus Erythematosus

Top Venues

Journal of medical economics

Global journal on quality and safety in healthcare

Cost effectiveness and resource allocation : C/E

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Gihan Hamdy Elsisi, Mohamed M Ibrahim Mahmoud, Khaldoon Al-Humood, Anas Al-Yousef
Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait. Journal of medical economics 27 (1) (2024)
Gihan Hamdy Elsisi, Gerardo Quintana, Diana Gil, Pedro Santos, Diana Fernandez
Clinical and economic burden of systemic lupus erythematosus in Colombia. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Gerardo Quintana, Diana Gil, Pedro Santos, Diana Fernandez
Clinical and economic burden of systemic lupus erythematosus in Colombia. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Mohamed M Ibrahim, Khaldoon Al-Humood, Anas Al-Yousef
Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait. Journal of medical economics (2024)
Gihan Hamdy Elsisi, Mohamed M Ibrahim Mahmoud, Khaldoon Al-Humood, Anas Al-Yousef
Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait. Journal of medical economics 27 (1) (2024)
Gihan Hamdy Elsisi, Mohamed M Ibrahim, Khaldoon Al-Humood, Anas Al-Yousef
Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait. Journal of medical economics (2024)
Gihan Hamdy Elsisi, Lilia Andrade-Ortega, Margarita Portela, Gabriel Medrano Ramírez
The economic burden of systemic lupus erythematosus in Mexico. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Lilia Andrade-Ortega, Margarita Portela, Gabriel Medrano Ramírez
The economic burden of systemic lupus erythematosus in Mexico. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Mohamed M Ibrahim Mahmoud, Khaldoon Al-Humood, Anas Al-Yousef
Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait. Journal of medical economics 27 (1) (2024)
Gihan Hamdy Elsisi, Lilia Andrade-Ortega, Margarita Portela, Gabriel Medrano Ramírez
The economic burden of systemic lupus erythematosus in Mexico. Journal of medical economics 27 (sup1) (2024)
Ahmed Swidan, Gihan Hamdy Elsisi, Mohamed M Ibrahim, Mohammad Aljazzar, Hossameldin Tawfik Sallam
Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait. Journal of medical economics (2023)
Gihan Hamdy Elsisi, Mariam Mohamed El-Attar, Shaimaa Mohamed Ismaeil, Mohamed El-Saeed El-Shater, Mary G Kirollos, Amal S Sedrak, Hany Morad, Heba Abdel-Mohsen, Mohamed Abdel-Aziz, Mohamed Magdy, Osama Loutfy
Estimation of Prostate Cancer Cost in Egypt From a Societal Perspective. Global journal on quality and safety in healthcare 6 (2) (2023)
Ahmed Swidan, Gihan Hamdy Elsisi, Mohamed M Ibrahim, Mohammad Aljazzar, Hossameldin Tawfik Sallam
Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait. Journal of medical economics 26 (1) (2023)
Gihan Hamdy Elsisi, Ayman Afify, Ashraf Abgad, Ibtissam Zakaria, Nabil Nasif, Hani Naiem Ibrahim, Nabil Raafat, João L Carapinha
A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt. Cost effectiveness and resource allocation : C/E 20 (1) (2022)
Magdy Abdelhamid, Gihan Hamdy Elsisi, Ahmed Seyam, Ahmed Shafie, Mary Kirollos, Sandy Emad, Shady Mansy, Mohamed Sobhy
Dapagliflozin cost-effectiveness analysis in heart failure patients in Egypt. Journal of medical economics 25 (1) (2022)
Gihan Hamdy Elsisi, Mohammed Moustapha Anwar, Mohamed Khattab, Ibrahim Elebrashy, Alaa Wafa, Hemat Elhadad, Mohamad Awad, João L Carapinha
Budget impact analysis for dapagliflozin in type 2 diabetes in Egypt. Journal of medical economics 23 (8) (2020)
Gihan Hamdy Elsisi, João L Carapinha, Rania Afify, Mohamed Abd Elmoty, Mohamed Khalaf
A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients. Journal of medical economics 23 (10) (2020)
Shereef Elsamany, Gihan Hamdy Elsisi, Fayza Hassanin, Mohamed Jafal
Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patients. Expert review of pharmacoeconomics & outcomes research 21 (3) (2020)
Gihan Hamdy Elsisi, Yousery Nada, Noha Rashad, João Carapinha, Ahmad O Noor, Diena M Almasri, Mostafa Al Zaidy, Ahmed Foad, Hussien Khaled
Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt. Journal of medical economics 23 (6) (2020)
Gihan Hamdy Elsisi, João Carapinha, Wagdy Amin, Ehab Thabet, Safaa Elafify, Mohamad Amin, Ashraf Hatem
A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt. Journal of medical economics 22 (10) (2019)